ATLANTA, May 18, 2021 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading cardiac and vascular surgery company focused
on aortic disease, announced today that it will participate in the
upcoming UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021. The Company's virtual
fireside chat is scheduled to begin at 11:00
a.m. ET.
A live webcast of the virtual fireside chat will be accessible
through CryoLife's website, www.cryolife.com, on the Investor
Relations page. An archived copy of the webcast will be available
for 90 days on the same website.
About CryoLife, Inc.
Headquartered in suburban
Atlanta, Georgia, CryoLife is a
leader in the manufacturing, processing, and distribution of
medical devices and implantable tissues used in cardiac and
vascular surgical procedures focused on aortic repair. CryoLife
markets and sells products in more than 100 countries worldwide.
For additional information about CryoLife, visit our website,
www.cryolife.com.
Contacts:
|
|
CryoLife
|
Gilmartin Group
LLC
|
D. Ashley
Lee
|
Brian Johnston / Lynn
Lewis
|
Executive Vice
President, Chief Financial Officer
and Chief Operating Officer
|
Phone:
631-807-1986
investors@cryolife.com
|
Phone:
770-419-3355
|
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryolife-to-participate-in-the-ubs-global-healthcare-virtual-conference-301293517.html
SOURCE CryoLife, Inc.